The Myasthenia Gravis-Specific Activities of Daily Living Profile

MG-ADL: Still a relevant outcome measure

(2011) Srikanth Muppidi et al.   MUSCLE & NERVE

History of outcome measures for myasthenia gravis

(2010) Ted M. Burns   MUSCLE & NERVE

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

(2010) Ted M Burns et al.   MUSCLE & NERVE

The MG Composite: A valid and reliable outcome measure for myasthenia gravis

(2010) T. M. Burns et al.   NEUROLOGY

Long-term Treatment of Steroid-dependent Myasthenia Gravis Patients with Low-dose Tacrolimus

(2008) Akiko Nagaishi et al.   INTERNAL MEDICINE

Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis

(2008) Gil I. Wolfe et al.   MUSCLE & NERVE

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

(2008)   NEUROLOGY

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

(2008) D. B. Sanders et al.   NEUROLOGY